CompaniesByCap
CRSP
Crispr Therapeutics AG (CRSP)
NASDAQ · Healthcare

Crispr Therapeutics AG PE Ratio 2016–2026

Current and historical P/E ratio for Crispr Therapeutics AG (CRSP), calculated by dividing the latest closing price by the trailing twelve-month earnings per share (EPS). As of it is —.
From: 03/31/2017To: 03/31/2026
Stock Price
TTM Net EPS
PE Ratio

Crispr Therapeutics AG PE Ratio — FAQ

Crispr Therapeutics AG (CRSP) pe ratio over the last 11 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see CRSP's pe ratio history?

The chart and table above show Crispr Therapeutics AG's pe ratio by year and by quarter, including the growth rate.